Terms: = Lymphoma AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Diagnosis
4 results:
1.
Wu X; Li Y; Zhang W; Zhang J; Chen B; Ge Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552804
[TBL] [Abstract] [Full Text] [Related]
2. Mechanisms and consequences of dysregulation of the Tiam family of Rac activators in disease.
Maltas J; Reed H; Porter A; Malliri A
Biochem Soc Trans; 2020 Dec; 48(6):2703-2719. PubMed ID: 33200195
[TBL] [Abstract] [Full Text] [Related]
3. First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
Martínez-Calle N; Alfonso A; Rifón J; Herrero I; Errasti P; Rábago G; Merino J; Panizo Á; Pardo J; Prósper F; García-Muñoz R; Lecumberri R; Panizo C
Eur J Haematol; 2017 Jan; 98(1):38-43. PubMed ID: 27232286
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of Tiam1 expression in papillary thyroid carcinoma.
Hsueh C; Lin JD; Yang CF; Chang YS; Chao TC; Sun JH; Wu IC; Tseng NM; Ueng SH
Virchows Arch; 2011 Dec; 459(6):587-93. PubMed ID: 22075848
[TBL] [Abstract] [Full Text] [Related]
